To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
GI Partners-backed Clinical Ink taps Goldman as CEO
Goldman succeeds Ed Seguine who has led Clinical Ink since nearly fourteen years ago.
